載入...
Evaluation of tamoxifen and simvastatin as the combination therapy for the treatment of hormonal dependent breast cancer cells
Tamoxifen (TAM) is a nonsteroidal antiestrogen drug, used in the prevention and treatment of all stages of hormone-responsive breast cancer. Simvastatin (SIM), a lipid-lowering agent, has been shown to inhibit cancer cell growth. The study aimed at investigating the impact of using SIM with TAM in e...
Na minha lista:
| 發表在: | Toxicol Rep |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6880098/ https://ncbi.nlm.nih.gov/pubmed/31788433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.toxrep.2019.10.016 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|